Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioSig Technologies ( (BSGM) ) has provided an announcement.
BioSig Technologies held a Special Meeting on July 30, 2025, where stockholders voted on several proposals related to the company’s stock and governance. The meeting was adjourned pending Nasdaq approval for Proposal 1, concerning the issuance of shares related to the acquisition of Streamex Exchange Corporation, and will resume on September 26, 2025. Proposals 2 through 6 were approved, including the issuance of convertible debentures, amendments to the long-term incentive plan, and changes to the company’s certificate of incorporation to increase authorized shares and classify the board of directors.
The most recent analyst rating on (BSGM) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.
Spark’s Take on BSGM Stock
According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.
BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.
To see Spark’s full report on BSGM stock, click here.
More about BioSig Technologies
Average Trading Volume: 1,117,862
Technical Sentiment Signal: Hold
Current Market Cap: $161.2M
See more data about BSGM stock on TipRanks’ Stock Analysis page.